In a transaction where a significant portion of the value hinges upon intangible assets, the IP due diligence that integrates financing, regulatory, and other factors — including reimbursement feasibility for pharmaceutical and medical device industries — likely will yield a comprehensive profile in a most efficient manner.
By taking a cross-disciplinary approach to your IP due diligence — across IP, regulatory, corporate transactions, venture capital, and health care — we are able to address interdependent issues that are often overlooked.
